Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Asset Utilization Ratio (2019 - 2025)

Eton Pharmaceuticals' Asset Utilization Ratio history spans 7 years, with the latest figure at 0.68 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 59.63% year-over-year to 0.68; the TTM value through Sep 2025 reached 0.68, down 59.63%, while the annual FY2024 figure was 0.72, 35.11% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.68 at Eton Pharmaceuticals, up from 0.46 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.82 in Q1 2024 and bottomed at 0.41 in Q1 2025.
  • The 5-year median for Asset Utilization Ratio is 0.74 (2022), against an average of 0.9.
  • The largest annual shift saw Asset Utilization Ratio skyrocketed 5397.33% in 2021 before it crashed 77.62% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.81 in 2021, then rose by 0.52% to 0.81 in 2022, then surged by 110.81% to 1.71 in 2023, then tumbled by 59.28% to 0.7 in 2024, then decreased by 2.12% to 0.68 in 2025.
  • Per Business Quant, the three most recent readings for ETON's Asset Utilization Ratio are 0.68 (Q3 2025), 0.46 (Q2 2025), and 0.41 (Q1 2025).